March 26, 2012

Intralesional PV-10 Treatment Leads to the Induction of Anti-Tumor Immunity

Following its Friday PR -- Mechanism of Action Data On PV-10 Demonstrates Therapy Induces Immunologic Response: (i) Leads to Regression of Untreated Lung and Cutaneous Melanoma Metastases and (ii) Results Detailed in Poster Presentation at the Society of Surgical Oncology Annual Meeting; Details of Poster Expected to Be Released Next Week -- Provectus released the second immunology-/SSO-related PR today.

The poster is below:

I below up some of the portions of the poster.

No comments:

Post a Comment